Physician Wealth Advisors’s Cambria Shareholder Yield ETF SYLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$294K Sell
3,721
-1,073
-22% -$84K 0.04% 161
2026
Q1
$362K Buy
4,794
+6
+0.1% +$448 0.05% 129
2025
Q4
$333K Buy
4,788
+143
+3% +$9.82K 0.05% 133
2025
Q3
$319K Sell
4,645
-28
-0.6% -$1.9K 0.05% 134
2025
Q2
$304K Sell
4,673
-187
-4% -$11.6K 0.05% 138
2025
Q1
$310K Sell
4,860
-1
-0% -$68 0.05% 132
2024
Q4
$333K Sell
4,861
-10
-0.2% -$722 0.06% 128
2024
Q3
$353K Sell
4,871
-553
-10% -$38.6K 0.06% 121
2024
Q2
$391K Sell
5,424
-9
-0.2% -$629 0.07% 107
2024
Q1
$377K Buy
5,433
+79
+1% +$5.42K 0.08% 108
2023
Q4
$360K Buy
5,354
+996
+23% +$62K 0.08% 108
2023
Q3
$266K Buy
+4,358
New +$273K 0.07% 119

Other funds holding SYLD

Physician Wealth Advisors's SYLD Position: Q2 2026 in Review

Physician Wealth Advisors reduced its Cambria Shareholder Yield ETF (SYLD) stake by 22% in Q2 2026, selling an estimated $84K and leaving 3,721 shares worth $294K. The position accounts for 0.04% of the portfolio, ranked #161.

Physician Wealth Advisors first reported a position in SYLD in Q3 2023 and has held it in 12 quarters since. The position peaked at $391K in Q2 2024. 166 funds tracked by Wall St. Rank hold SYLD as of Q2 2026.

  • Physician Wealth Advisors held 3,721 shares of Cambria Shareholder Yield ETF worth $294K as of Q2 2026.
  • Physician Wealth Advisors sold 1,073 Cambria Shareholder Yield ETF shares in Q2 2026, an estimated $84K.
  • Cambria Shareholder Yield ETF made up 0.04% of Physician Wealth Advisors's portfolio in Q2 2026, its #161 holding.
  • Physician Wealth Advisors first reported a position in Cambria Shareholder Yield ETF in Q3 2023 and has held it in 12 quarters since.
  • Physician Wealth Advisors's Cambria Shareholder Yield ETF position peaked at $391K in Q2 2024.
  • 166 funds tracked by Wall St. Rank held Cambria Shareholder Yield ETF as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.